On behalf of the U.S. Centers for Disease Control and Prevention (CDC), I would like to officially welcome you to the CDC-Nigeria homepage on the U.S. Embassy Website.
The CDC-Nigeria Country Office—established in 2001 and housed on the U.S. Embassy compound in Abuja—aims to achieve “Public Health Excellence for Healthy Nigerians” by working closely with the Government of Nigeria, local implementing partners, and other agencies of the U.S. Government and, collaboratively, strengthening Nigeria’s public health infrastructure through various public health programs and initiatives. With more than 90 staff and 16 implementing partners (IPs), we support the Nigerian Federal Ministry of Health to implement key public health programs, evaluate disease surveillance and response efforts, and contribute to reinforcing the existing public health infrastructure.
CDC-Nigeria is comprised of four major divisions—HIV, Immunization, Malaria, and Global Health Security—which work together to deliver on our mission. I encourage you to read more about all of this important work here on our website, and, should you have any questions or comments, please contact us at (234) (0)9-461-4000.
Dr. Adetinuke (Mary) Boyd
Country Director, CDC-Nigeria
Dr. Adetinuke (Mary) Boyd is the CDC Nigeria Country Director having been appointed to this position in April 21, 2021. In this role, Dr. Boyd is leading one of CDC’s largest country offices and support CDC’s collective efforts in global HIV and TB, global health security, malaria elimination, and immunization. Since October 2020, Dr. Boyd has served as a Senior Advisor for HIV and TB Prevention for CDC Nigeria and as a regional and international expert on HIV and TB prevention.
Dr. Boyd is a trained vaccinologist and conducted vaccine trials for influenza A (H1N1), live oral Shigella, Vibrio cholera and Salmonella vaccine candidates from 2009-2013 at the University of Maryland’s Center for Vaccine Development. She subsequently joined the Food and Drug Administration, where she led global health vaccine efforts, including for Ebola, from 2013-2016. Dr. Boyd joined CDC in the CDC Zambia country office, where she first served as Deputy Associate Director for Programs (2016-2018) and then as Senior Medical Advisor (2018-2020). Dr. Boyd’s accomplishments in Zambia included leading the Antiretroviral Treatment Surge campaign; establishing the Zambia National HIV Clinical Mentorship program; and directing the first regional COVID-19 response ECHO community of practice in Southern Africa and West Africa.
Commander Dr. Boyd is an active duty physician in the Commissioned Corps of the U.S. Public Health Service, and currently performs clinical practice at the U.S. Embassy Abuja Health Unit. She received her undergraduate degree in neurobiology and physiology from the University of Maryland, College Park, and completed her medical degree, residency and fellowship in pediatrics and infectious diseases at the University of Maryland, Baltimore. Dr. Boyd is a proud Terrapin, a Zumba fanatic, and enjoys traveling with her husband and 3 kids.
Suzanne Theroux is currently the CDC Nigeria Country Deputy since April 2021, having held a similar position as the CDC Mozambique Country Deputy from 2018 to 2021. In this role, she oversees the management of the office comprised of 11 U.S. direct hires and 94 locally employed staff. In addition, Suzanne manages the coordination of PEPFAR initiatives across four deputies, an Associate Director, and 9 Branches. She acts as a senior representative for CDC on the PEPFAR management planning team, directs communications with key HHS and CDC offices, and liaises with a senior partner and government to government engagements. In addition, coordinate with U.S. Embassy Front Office for PEPFAR activities and CDC strategic issues and liaises with the management, finance, procurement, and human resources business offices for routine administrative actions.
She served as the Director of the for Overseas Operations Office at CDC’s Center for Global Health (CGH) from 2015 to 2018. In that position, Suzanne was responsible for managing operations of 50+ country offices and supported 500+ global direct hires/contractors and 1400+ locally employed staff. In addition, providing country office administrative services including Department of State agreements/billings, facilities management/security, and oversight of renovation/construction; global staff management, including recruitment/hiring/deployment, relocation procedures, and emergency services; workforce management, including coordination of regional training, organizational development assistance, and oversight of locally employed staff; operational policy.
Suzanne had held several other positions, including Deputy Director for Management CDC Kenya, 2009 to 2014; Deputy Director – Program Unit, CDC Uganda Global AIDS Program, and Regional Program Consultant for Department of Health and Human Services, 2004 to 2009. In addition, she spent several years working in public health in the areas of family planning, and reproductive health, education, and capacity development.
In addition to several years of experience working with the CDC and HHS, she worked with Johns Hopkins University Program for International Education in Reproductive Health, Management Sciences for Health, Pathfinder International, Planned Parenthood of New York City, and was a Peace Corps Volunteer in West Africa. Suzanne holds a Bachelor of Science degree from the University of New Hampshire and a Master of Public Health from the Columbia University School of Public Health.
Nigeria is the third-largest U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program and has received over $4 billion since 2004. CDC-Nigeria works in close collaboration with Nigeria’s Federal Ministry of Health (FMOH) to support sustainable, country-owned HIV prevention, treatment, and care programs and to strengthen the country’s laboratory, disease surveillance, and program monitoring and evaluation systems.
CDC-Nigeria has provided
Specifically, CDC-Nigeria is working to address the impact of HIV/AIDS through:
CDC-Nigeria is responding to challenges in maintaining high-quality surveillance systems and strengthening the public health disease response to outbreaks in Nigeria. To achieve high impact, CDC-Nigeria supports GoN to conduct routine HIV/AIDS prevalence survey through sentinel antenatal clinic attendees and provides technical assistance to other general and high-risk population studies. CDC-Nigeria collects accurate health data and uses the data to plan, implement, and evaluate programs. A high-quality epidemiological surveillance system allows Nigeria to tailor programs to the local epidemic and direct resources to the areas with the highest need. CDC’s top priorities are to ensure high data quality and create quality surveillance systems throughout the country. In this regard CDC-Nigeria’s epidemiology program has been the bedrock of PEPFAR programs, providing monitoring, evaluation, and strategic information services that include regular site monitoring and supervisory visits; managing facility-level monthly program reports and conducting facility-level data quality validation and assessments; general population, Sentinel and target group surveys.
Specifically, CDC-Nigeria’s Epidemiology-Strategic Information program provides technical and logistics support and training to Nigeria to conduct significant ongoing surveillance programs, surveys, and individual studies. These include HIV incidence study, National antiretroviral therapy impact and outcome evaluations, Prevention of Mother-to-child Transmission (PMTCT) impact evaluation study. It also provides State level AIDS indicator survey and Drug resistance monitoring surveys
Since 2006, CDC-Nigeria has provided funding and technical assistance to the Government of Nigeria and implementing partners for coordinated TB/HIV efforts in Nigeria. The CDC-Nigeria TB/HIV program works to strengthen TB/HIV collaboration within the Federal Ministry of Health, State Ministries, and PEPFAR-supported TB/HIV partners and support the use of new technologies such as GeneXpert for timely TB diagnosis for people living with HIV. Using the 3 ‘Is’ approach; CDC-Nigeria supports Intensified case finding–Regular TB screening for people with HIV and people with high HIV risk. It also carries out Isoniazid preventive therapy–Treatment to prevent latent TB infections from developing into active TB and the TB Infection control–Detect TB infections, prevent airborne transmission, and treat those with TB infections in line with TB BASICS (Building and Strengthening TB Infection Control Strategies) model. Also, core to the TBHIV program is the scale-up of ART services for HIV-infected TB patients, treatments of their TB as well as the strengthening of TB/HIV monitoring and evaluation systems.
CDC-Nigeria programs for children orphaned and made vulnerable by HIV/AIDS contributes to the achievement of an AIDS-free generation by responding to the social (including economic) and emotional consequences of the disease on children, their families, and communities that support them. CDC-Nigeria collaborates with relevant government ministries, departments and agencies (especially the Federal and State Ministries of Women Affairs and Social Development), Implementing partners and other stakeholders to deliver OVC program services.
CDC-Nigeria Implementing Partners work with health facilities, community-based organizations (CBOs), civil society organizations (CSOs), faith-based organizations (FBOs), etc. to provide community and facility child-focused, family-centered interventions/OVC services to beneficiaries. Service package includes health and nutrition, education, psychosocial support, household economic strengthening, child and legal protection, adolescent girls and young women program, etc.
CDC-Nigeria supports Government of Nigeria to scale up comprehensive HIV treatment, care and support program which is patient-centered and focuses on quality services. The program aims to reduce HIV burden and mortality by increasing access to ART for HIV-infected individuals inclusive of children hence contributing to an AIDS-free generation where no Nigerian child dies on account of HIV infection. Since 2004, Care and support for adults and pediatrics living with HIV/AIDS has evolved from the provision of palliative care and management of myriads of opportunistic infection to the current client tailored needs. This approach is centered on positive health, dignity and prevention services in the health facility and community, adequate adherence preparation before the commencement of ART and laboratory monitoring of patients on ART using viral load testing. CDC has been working to coordinate HIV treatment, care and support efforts in Nigeria and to strengthen the Government of Nigeria’s ownership of HIV treatment services.
CDC’s technical support will continue to be essential in helping the Government of Nigeria expands HIV treatment services in ways that will significantly reduce unmet needs. The treatment program intends to accomplish this by doing the ‘right things’ that is implementing the right package of care that will improve the quality of life and reduce morbidity and mortality. Additionally, CDC’s program Implementation is focused in the ‘right places,’ that is scaling up of treatment services in the most HIV-burdened local government areas in Nigeria, and by leveraging locally available resources to achieve synergy, and improving overall efficiency through the implementation of concepts that strengthens the health systems in Nigeria. Also, to supporting expanded access and quality of ART services, CDC is work with IP and Government of Nigeria to develop programs that will demonstrate sustained control of the HIV epidemic and long-term sustainability.
CDC-Nigeria also works with local groups who go to the homes of clients who test positive for HIV. The groups provide home-based HTC so family members also can connect to nearby hospitals or clinics for services. This approach is focused on populations with highest HIV risk, including prison inmates, people in alcohol/drug rehabilitation centers, sex workers, families of people diagnosed with HIV, and pregnant women and their children.
CDC-Nigeria Prevention of Mother-to-Child Transmission (PMTCT) program has led the effort to strengthen Nigeria’s health system so that all women have access to testing, lifelong ART, care, and support. The HIV testing of all pregnant women and provision of lifelong antiretroviral therapy (ART) for those found to be HIV positive is very effective in preventing the transmission of HIV from mother to child. The PMTCT program supports health facilities in thirty-two selected priority local governments across eight supported states in Nigeria to pilot option B+ in line with the latest WHO guidelines.
CDC-Nigeria works on many fronts to assure that PMTCT activities are effective, cost efficient, and sustainable in all their supported states and facilities. The efficiency is achieved through partnerships with States and local indigenous organizations who can provide PMTCT services and collaborate with public and private health facilities to scale up PMTCT in areas with the highest HIV burden. CDC also works with GoN and other stakeholders in the field of policy and capacity building and development to strengthen the provision of PMTCT services in health facilities.
In Nigeria, 80% of new HIV infections is acquired through unprotected sex (National Strategic Plan; 2010 – 2015). Since 2007, CDC-Nigeria’s Sexual Transmissions Program (STP) has been working to reduce sexual transmission of HIV, especially in subpopulations with the highest risk of exposure. Since CDC-Nigeria launched STP in 2007, the program has played a significant role in the steady decline in national HIV prevalence. By building the capacity of local implementing partners and CBOs to raise community awareness, and develop skills on HIV prevention and safer sex. The STP program is helping to build a stronger health care infrastructure in Nigeria. In addition to influencing the general population, CDC-Nigeria’s partners have been able to design and implement programs for Key Populations not previously reached.
Gender norms, inequalities, and violence increase women’s/girls and men’s/boys vulnerability to HIV due to multiple socio-cultural factors, including limited the ability to negotiate safer sex. It also encourages engaging in transactional sex, high sexual risk behaviors, and curtailed ability to test, disclose and access HIV treatment because of real or perceived fear of violence and abandonment. CDC-Nigeria, through its implementing partners, works to promote gender equity and equality in its HIV program by engaging women and girls, men and boys to address norms and behaviors that contribute to the HIV epidemic. Due to the intersections between gender-based violence (GBV) and HIV, CDC-Nigeria also recognizes the intersections between gender-based violence and HIV and is providing comprehensive health services to survivors of GBV and providing referral linkages for non-clinical services.
The medical laboratory is the backbone of our public health programs and interventions. We partner with the Government of Nigeria through the Laboratory services program, to support the provision of integrated and quality assured public health laboratory services for the diagnosis, staging, treatment monitoring, and laboratory-based surveillance of HIV/AIDS, Tuberculosis, and other related diseases. Our principal areas of strategic focus are Laboratory Service provisions, Laboratory Quality Improvement, and laboratory capacity building and systems strengthening.
Through our PEPFAR program, Implementing Partners CDC/Nigeria is supporting laboratory services for HIV and related diseases in over 213 public and private laboratories across the six geopolitical zones of Nigeria, with an astute focus on achieving the PEPFAR Nigeria 90-90-90 targets as a strategy towards attaining an AIDS-Free Generation. CDC is leading the coordination of a USG inter-agency (USAID, DOD, and CDC) efforts in the provision of viral load, early infant diagnosis, CD4 count, TB GeneXpert tests across the 36 states of the Nigeria and the FCT, through a network of about 500 PEPFAR supported laboratories.
As part of our Systems Strengthening and continuous quality improvement efforts, CDC/Nigeria is supporting and providing the needed technical assistance for the implementation of a Proficiency Testing Program in Nigeria, through the National External Quality Assurance Laboratory (NEQAL), established through CDC funding support. Through this lab, CDC is also supporting the Post-market validation of all procured HIV Rapid test kits to ensure their reliability before they are deployed for use in HIV testing sites.
We are currently leading the efforts of institutionalizing Quality Management Systems (QMS) implementation in all PEPFAR supported laboratories in Nigeria using the Strengthening Laboratory Quality Management Towards Accreditation (SLMTA) program as an implementation strategy in this direction. Through this efforts, a significant number of laboratories have achieved varying degrees of Stars levels in recognition of their quality improvement efforts.
CDC has worked in collaboration with Stakeholders’ to develop a National Medical Laboratory Strategic Plan for 2015 – 2020, and we are supporting the implementation of this strategic plan, in partnership with other donors and development partners in Nigeria. CDC is also collaborating with the Clinton Health Access Initiatives in the implementation of a National Laboratory Information Management System (LIMS) in supported molecular and clinical laboratories.
CDC-Nigeria is part of the President’s Malaria Initiative and provides technical assistance to help reduce the burden of Malaria in Nigeria. CDC provides assistance with Malaria surveillance, evaluation of programs, and operations research to assess what is working. This information is used to modify programs and improve Nigeria’s Malaria strategy.
FELTP trains field public health laboratory, epidemiology, and veterinary epidemiology residents to work in leadership positions in the Ministry of Health and the Federal Ministry of Agriculture and Water Resources. This two-year program helps improve public health systems within the country by increasing knowledge and skills in field epidemiology and laboratory science and building a cadre of skilled and well-trained health professionals in Nigeria.
Nigeria’s program is the first applied epidemiology training program of its kind to offer a field veterinary epidemiology track. N FELTP introduced the Veterinary track to address the increasing threat of zoonotic and epizootic diseases in Nigeria. After residents have completed all requirements of the program, they receive the Master of Public Health degree in Field Epidemiology, Veterinary Epidemiology, or Laboratory Epidemiology and Management through their affiliated universities.
A robust public health infrastructure is critical to prepare Nigeria for public health emergencies such as infectious and noninfectious disease outbreaks. Since 2004, the CDC-Nigeria Health Systems Strengthening (HSS) program has worked to build local capacity to respond to HIV/AIDS and other diseases. The overarching goals of CDC-Nigeria’s HSS program are to instill ownership, build local capacity, and sustain the delivery of quality healthcare services to citizens of Nigeria in an integrated and comprehensive manner.
CDC-Nigeria worked with the Government of Nigeria and other partners in the establishment and operation of the Nigeria Centers for Disease Control and the National Public Health Reference Laboratory for efficient disease detection and surveillance. It is also working with partners to institutionalize in-service training programs toward establishing national centers of excellence for training in various areas of HIV/AIDS care and management.
CDC partnered with Population Services International in Nigeria to launch WaterGuard, a water treatment product. CDC staff conducted an evaluation of the impact of existing safe water treatment and storage programs.
CDC-Nigeria’s Global Immunization Division provides ongoing technical support to strengthen Nigeria’s routine immunization program and to help the country meet national immunization goals and international resolutions to eradicate polio and reduce measles mortality. The Global Immunization program and national counterparts developed an innovative advocacy and communication strategy (the “Gezawa Initiative”) to engage traditional Muslim leadership in polio eradication activities more fully and conduct social mobilization activities in high-risk communities in Northern Nigeria.
In July 2012, CDC and the Nigerian Field Epidemiology and Laboratory Training Program (N-FELTP) collaborated to establish the National Stop Transmission of Polio (NSTOP) program. Highly trained NSTOP staff fills gaps in polio eradication program management in the highest risk local government areas in northern Nigeria.
As a founding member of the Global Polio Eradication Initiative, the Centers for Disease Control and Prevention’s (CDC) Global Immunization Division supports the Nigerian government in its efforts to kick polio out of Nigeria.
CDC developed and implemented a two-tiered dashboard system that tracks vaccination campaign performance in all high-risk states. The dashboard has been an important source of data for planning and improving the quality of campaigns. CDC and NSTOP also train and mentor state and local government area Immunization Officers to improve their data reporting and analysis capacity.
CDC and NSTOP are working to strengthen the routine immunization system in 13 northern states. The work CDC carries out includes improving cold chain storage, vaccine management, service delivery, and data management. CDC and NSTOP have developed applied training modules on routine immunizations for LGA immunization officers and other partner staff.
In 2007, CDC helped to establish a National Influenza Reference Laboratory and provided technical support, supplies, and reagents to the laboratory. In 2009, the U.S. Government officially handed over the fully functional National Influenza Reference Laboratory to the Government of Nigeria. CDC has also helped establish the first ever National Influenza Sentinel Surveillance System, which monitors influenza occurrence in clinics and hospitals and detects new influenza strains with pandemic potential. CDC trains doctors, nurses, pharmacists, epidemiologists, and laboratorians to better manage influenza.
The Global Health Security Agenda (GHSA) is a unifying framework to improve the global response to disease outbreaks and close gaps in surveillance and intervention. Focused on health systems broadly as opposed to disease-specific initiatives, GHSA builds upon existing programs and policies to improve health and spur progress toward full implementation of the World Health Organization’s (WHO) International Health Regulations 2005 (IHR). While Nigeria has not formally signed on to GHSA, the country did agree to meet its obligations under the IHR in 2005. CDC’s Division of Global Health Protection (DGHP) works with the Government of Nigeria and other partners to achieve these requirements by focusing on workforce development, emergency response, surveillance, laboratory, and border health/point of entry interventions.
Now in its second year of GHSA implementation in Nigeria, CDC’s work with two of its implementing partners the University of Maryland-Baltimore and Pro-Health International- has seen many accomplishments in the areas of surveillance and border health issues. CDC’s support also includes targeted technical assistance; oversight on workforce development through the Nigeria Field Epidemiology and Laboratory Training Program, which builds capacity among the Nigerian public health workforce. Additionally, there are efforts to harmonize Nigeria’s various national and state Emergency Operations Centers; and exploring ways to strengthen existing laboratory networks by partnering with the Nigeria Centre for Disease Control as well as other laboratory partners.
|1||Achieving Health in Nigeria||AHNI|
|2||African Field Epidemiology Network||AFENET|
|3||AIDS Prevention in Nigeria||APIN|
|4||Center for Clinical Care and Clinical Research in Nigeria||CCCRN|
|5||Catholic Caritas Foundation of Nigeria||CCFN|
|6||Center for Integrated Health Program||CiHP|
|7||Excellence Community Education and Welfare Scheme||ECEWS|
|8||Friends for Global Health Initiative in Nigeria||FGHiN|
|9||Institute of Human Virology||IHVN|
|10||National Primary Health Care Development Agency||NPHCDA|
|12||Safe Blood for Africa Foundation||SBFAF|
|13||University of Maryland Baltimore||UMB|
|14||Association of Public Health Laboratories||APHL|
|15||African Society for Laboratory Medicine||ASLM|
|16||American Society for Microbiology||ASM|
|17||Nigeria Center for Disease Control||NCDC|